THE HETEROGENEITY OF GLIOBLASTOMA AND TREATMENTS

Authors

  • Gabriela Corrêa de Sousa Universidade Brasil
  • Dorival Scantamburlo Junior Universidade Brasil
  • Luciana Estevam Simonato Universidade Brasil- Fernandopolis

DOI:

https://doi.org/10.51891/rease.v7i12.3387

Keywords:

Glioblastoma. Heterogeneity. Treatments.

Abstract

Objective: This study aimed to describe glioblastoma, showing its epidemiology and histological characteristics. Also, show the types of diagnostic tests and treatments available. Methods: Surveys of scientific productions that addressed glioblastoma as a central theme, written in English or Portuguese, published from 2000 to 2020, were carried out. Conclusion: Glioblastoma is a primary brain tumor very prevalent in adults and often asymptomatic at first with nonspecific symptoms having a difficult and late diagnosis, with complex treatment. However, the prognosis of the disease is poor, with a survival of 4 to 6 months in patients who opt for no treatment and 14 months on average in patients with multimodal treatment.

Author Biographies

Gabriela Corrêa de Sousa, Universidade Brasil

Médica formada pela Universidade Brasil – Fernandopolis, São Paulo no ano 2021.

Dorival Scantamburlo Junior, Universidade Brasil

Médico formado pela Universidade Brasil – Fernandopolis , São Paulo No ano 2021.

Luciana Estevam Simonato, Universidade Brasil- Fernandopolis

Cirurgiã-dentista Doutorada em engenharia biomedica. Docente dos cursos de medicina e odontologia da Universidade Brasil- Fernandopolis , São Paulo. Mestre em estomatologia.

Downloads

Published

2021-12-30

How to Cite

Sousa, G. C. de ., Scantamburlo Junior, D. ., & Simonato, L. E. . (2021). THE HETEROGENEITY OF GLIOBLASTOMA AND TREATMENTS. Revista Ibero-Americana De Humanidades, Ciências E Educação, 7(12), 194–205. https://doi.org/10.51891/rease.v7i12.3387

Issue

Vol. 7 No. 12 (2021): Revista Ibero- Americana de Humanidades, Ciências e Educação.

Section

Artigos

Categories

License

Atribuição CC BY